Open original FDA record ↗Recall record
- FDA identifier
- Z-2016-2025
- Company in FDA record
- Insulet Corporation
- FDA classification date
- Jun 24, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Insulet Corporation is recalling Omnipod 5 iOS App, due to a software design issue in which a comma is not recognized as a decimal separator and the user cannot enter a decimal separator in any manual entry screen if the user manually updates their phone settings to a region OUS that uses a decimal separator instead of a period decimal separator or chooses that format as a preference. Use of the affected software may result in over delivery of insulin by increasing the amount of insulin when a decimal separator is not recognized (e.g., 0.1 unit recognized as 1 unit) and thus may result in hypoglycemia, potentially severe.
Source facts
- Action
- Insulet notified health care professionals and users on 05/23/2025 via emailed letter. Consignees were instructed to make sure your phone s keyboard and region settings match the approved country for use currently, the U.S. only and this issue does not affect the Insulet-provided Omnipod 5 Controllers or the Omnipod 5 App on compatible Android phones. A software update will be pushed to all devices in the coming weeks, and each consignee will be notified via email and in-app notification on the device when it is ready to install. The fix will allow commas to be recognized as decimal points when using the Omnipod 5 App for iPhone. The email notification to users included a section to formally acknowledge the notification.
- Initiated
- 2025-05-23
- Root cause
- Software design
- Distribution
- US market only- Although there are 122823 downloads of the application, our data shows there are only ~80k active users.
- Recall number
- Z-2016-2025
- Recall status
- Open, Classified
- CDRH record ID
- 214077
- FDA classified
- 2025-06-24
- Recall event number
- 96945